| Jul 9 |
FTC Chair Khan slams PBMs for higher drug prices in an interim report on the industry
|
| Jul 9 |
Why Kymera Therapeutics Stock Is Soaring Today
|
| Jul 9 |
3 Stocks to Sell Immediately Based on the French Election Results
|
| Jul 9 |
Kymera Therapeutics soars as Sanofi expands phase 2 trials
|
| Jul 9 |
Kymera Therapeutics Soars as Sanofi Expands Studies of Its Skin Diseases Drug
|
| Jul 9 |
Kymera's (KYMR) Partner SNY to Expand Ongoing HS and AD Studies
|
| Jul 8 |
Kymera announces expansion of KT-474 HS and AD phase 2 studies
|
| Jul 8 |
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
|
| Jul 8 |
Questor: Top fund managers are betting this pharma giant turns things around
|
| Jul 5 |
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
|
